Introduction
Leading pharmaceutical manufacturer announces launch of a clinically researched probiotic formulation in India, offered in multiple strengths to support gut microbiota balance and various gastrointestinal health conditions across diverse patient needs.
Also Read: Mahindra Holidays: Stock zooms 5% after entering new ‘Leisure Hospitality’ segment
Share price movement of Alkem Laboratories
On November 21, 2025, Alkem Laboratories Ltd opened at ₹5,708.05, up 0.10% from its previous close of ₹5,702.35. The stock reached a high of ₹5,723.30 (0.37%) and a low of ₹5,640.00 (-1.09%). By 11:59 AM, it traded at ₹5,656.00, a 0.81% decline, with a market cap of ₹67,625.96 crore.
Alkem Launches DSS Probiotic Range
Alkem Laboratories Ltd announced the launch of DSS, the original De Simone formulation probiotic, in India on November 20, 2025. The product supports gut microbiota balance and various gastrointestinal health conditions.
The formulation includes eight bacterial strains selected for specific biochemical and enzymatic roles. It is supported by over 80 clinical trials and 200 publications. Alkem has in-licensed the formulation from Next Gen Pharma India Pvt. Ltd.
DSS will be available in four strengths, including two first-time strengths in India. The probiotic is indicated for IBS, Ulcerative Colitis, Pouchitis, Hepatic Encephalopathy, NAFLD, Cirrhosis, Bacterial Vaginosis and Antibiotic-Associated Diarrhea.
Stock performance of Alkem Laboratories for Period of 1 week, 6 months, and 1 year
Alkem Laboratories Ltd delivered a 0.39% decline over the past week, while it recorded a 7.79% gain in the past six months. The stock also posted a 1.70% gain over the past year.
Also Read: Varun Beverages: Stock jumps after incorporating wholly-owned subsidiary in Kenya
Shareholding pattern of Alkem Laboratories
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
| Promoter | 51.20% | 53.00% | 55.10% |
| FII | 9.50% | 9.10% | 9.40% |
| DII | 21.90% | 21.80% | 19.40% |
| Public | 17.40% | 16.10% | 16.10% |
About Alkem Laboratories
Alkem Laboratories Ltd (NSE: ALKEM) is a global pharmaceutical company involved in the development, manufacturing and sale of pharmaceutical and nutraceutical products, offering a wide portfolio across multiple therapeutic segments and international markets.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
A: Alkem Laboratories Ltd share price is up as the company launched DSS probiotic in India based on the De Simone formulation.
A: Alkem Laboratories Ltd specializes in developing, manufacturing and selling pharmaceutical and nutraceutical products across multiple therapeutic categories.
A: The 52-week high of Alkem Laboratories Ltd stock is ₹5,867.50, and the 52-week low is ₹4,498.90.
